ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Hemostemix Inc (QB)

Hemostemix Inc (QB) (HMTXF)

0.065652
0.00165
(2.58%)
Closed 28 April 6:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.065652
Bid
0.032
Offer
0.1699
Volume
70,000
0.065652 Day's Range 0.065886
0.024 52 Week Range 0.285
Market Cap
Previous Close
0.064
Open
0.065886
Last Trade Time
Financial Volume
US$ 4,612
VWAP
0.065886
Average Volume (3m)
28,207
Shares Outstanding
141,641,969
Dividend Yield
-
PE Ratio
-5.08
Earnings Per Share (EPS)
-0.02
Revenue
200k
Net Profit
-2.5M

About Hemostemix Inc (QB)

Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) fro... Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) from a synergetic cell population that is sourced from the patient's blood. The Company is selling exempt compassionate treatments to individuals afflicted with critical limb ischemia, for example, and conducting clinical trials to commercialize its lead product, ACP-01, for the treatment of critical limb ischemia and peripheral arterial disease, and heart disease (ischemic cardiomyopathy, dilated cardiomyopathy). Show more

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Headquarters
Calgary, Alberta, Can
Founded
2014
Hemostemix Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker HMTXF. The last closing price for Hemostemix (QB) was US$0.06. Over the last year, Hemostemix (QB) shares have traded in a share price range of US$ 0.024 to US$ 0.285.

Hemostemix (QB) currently has 141,641,969 shares in issue. The market capitalisation of Hemostemix (QB) is US$9.07 million. Hemostemix (QB) has a price to earnings ratio (PE ratio) of -5.08.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0046527.62622950820.0610.0658860.06123800.064CS
40.01165221.57777777780.0540.070250.05435650.06642541CS
12-0.160848-71.01456953640.22650.22650.054282070.12201867CS
260.033352103.2569659440.03230.2850.0323400920.17258155CS
520.02855276.95956873320.03710.2850.024325680.13538043CS
156-0.183348-73.63373493980.2490.32790.024232150.13245084CS
2600.058752851.478260870.00690.43720.0051355290.09619795CS

HMTXF - Frequently Asked Questions (FAQ)

What is the current Hemostemix (QB) share price?
The current share price of Hemostemix (QB) is US$ 0.065652
How many Hemostemix (QB) shares are in issue?
Hemostemix (QB) has 141,641,969 shares in issue
What is the market cap of Hemostemix (QB)?
The market capitalisation of Hemostemix (QB) is USD 9.07M
What is the 1 year trading range for Hemostemix (QB) share price?
Hemostemix (QB) has traded in the range of US$ 0.024 to US$ 0.285 during the past year
What is the PE ratio of Hemostemix (QB)?
The price to earnings ratio of Hemostemix (QB) is -5.08
What is the cash to sales ratio of Hemostemix (QB)?
The cash to sales ratio of Hemostemix (QB) is 64.29
What is the reporting currency for Hemostemix (QB)?
Hemostemix (QB) reports financial results in CAD
What is the latest annual turnover for Hemostemix (QB)?
The latest annual turnover of Hemostemix (QB) is CAD 200k
What is the latest annual profit for Hemostemix (QB)?
The latest annual profit of Hemostemix (QB) is CAD -2.5M
What is the registered address of Hemostemix (QB)?
The registered address for Hemostemix (QB) is SUITE 1150, 707-7TH AVE SW, CALGARY, CALGARY, ALBERTA, T2P 3H6
What is the Hemostemix (QB) website address?
The website address for Hemostemix (QB) is www.hemostemix.com
Which industry sector does Hemostemix (QB) operate in?
Hemostemix (QB) operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZHCLFZenith Capital Corporation (CE)
US$ 0.10
(99,900.00%)
27.91k
MJNEMJ Holdings Inc (CE)
US$ 0.0002
(19,900.00%)
1.45k
PPJEPPJ Healthcare Enterprises Inc (PK)
US$ 0.0001
(9,900.00%)
7.05M
IWSYImageWare Systems Incorporated (CE)
US$ 0.0001
(9,900.00%)
648.47k
BFYWBetter For You Wellness Inc (CE)
US$ 0.0001
(9,900.00%)
360
TMPOQTempo Automation Holdings Inc (CE)
US$ 0.000001
(-100.00%)
1.39k
LLBOLifeline Biotech Inc (CE)
US$ 0.000001
(-99.83%)
29.87k
NXGMNexGen Mining Inc (CE)
US$ 0.000001
(-99.50%)
60k
BRSIBallistic Recovery Systems Inc (CE)
US$ 0.000001
(-99.50%)
200
WHENWorld Health Energy Holdings Inc (PK)
US$ 0.000001
(-99.33%)
9.61M
CGACCode Green Apparel Corp (PK)
US$ 0.00055
(83.33%)
403.25M
VTXBVortex Brands Company (PK)
US$ 0.0002
(100.00%)
395.07M
RDARRaadr Inc (PK)
US$ 0.0009
(12.50%)
382.29M
TMSHTransGlobal Assets Inc (PK)
US$ 0.0003
(-25.00%)
256.45M
PSWWPrincipal Solar Inc (PK)
US$ 0.0003
(-40.00%)
140.74M

HMTXF Discussion

View Posts
georgie18 georgie18 2 weeks ago
Volume is what I am watching for...🥳no need to let me know I am watching...thanks...
👍️0
rodman rodman 2 weeks ago
Volume will move it up so watch for a big pop. Let you know when i do a big buy and you can jump in on at .05?
Thanks
rod
👍️0
georgie18 georgie18 2 weeks ago
There was no movement so I am out until I see it move...🥳
👍️0
rodman rodman 2 weeks ago
Have to ask how long and how invested are you in HMTXF if you don't mind?
Richard
👍️0
rodman rodman 1 month ago
Timing is everything!
👍️0
georgie18 georgie18 2 months ago
HMTXF...089...🥳...OTC partnering with a NAZ company sounds promising to me...Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for various forms of cardiovascular disease, including vascular dementia, announces its collaboration with Firefly Neuroscience, Inc. (NASDAQ: AIFF) ("Firefly"), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders.

Hemostemix and Firefly will study brain wave activity in up to 100 patients before and after treatment with ACP-01 at baseline, 3-months, and 6-months post-treatment (the "Phase 1").

https://www.otcmarkets.com/stock/HMTXF/news/Hemostemix-and-FireFly-Neurosciences-Brain-Network-Analytics-BNATM-Engage-to-Complete-Phase-1-Vascular-Dementia-Clinical?id=469780
👍️0
rodman rodman 2 months ago
Still following Hemostemix? I would be engaged for the short run up!
$1+
👍️0
rodman rodman 2 months ago
Looking like Hemostemix may be an emerging leader in the stem cell arena? Now the recent pr announced the lowest COGS cost of goods in the industry?
$1.+
👍️0
JamesMacho JamesMacho 1 year ago
Investors in $HEM are still waiting for any positive financial data to emerge, but so far, it's been a disappointing journey.
👍️0
tw0122 tw0122 2 years ago
Boom boom time
👍️0